Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 80 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
791 13.5 months Hormone-refractory prostate cancer 4 Chemotherapy
Johns Hopkins Medical Institutions United States 3/2002
Treatment Details: Patients: This Phase II study involved 42 patients with androgen independent prostate cancer. The median age was 68 years. Sites of metastasis included bone, soft tissue, and lymph nodes.
 
792 13.5 months Newly diagnosed GBM Chemotherapy
Radiation
Surgery
Western Pennsylvania Cancer Institute United States 8/2002
Treatment Details: Patients: This study involved 270 patients (subjects in the “Valid Study Group”) divided into two groups. Group 1 contained 137 patients. Of these 137 patients, 123 had newly diagnosed gli
 
793 13.5 months Newly diagnosed GBM Chemotherapy
Radiation
Surgery
University Hospital Eppendorf Germany 4/2003
Treatment Details: Patients: This Phase III study involved 240 patients, half of whom received the BCNU (gliadel) wafer. Of the 120 patients who received the wafer, 101 had glioblastoma multiforme, 13 had ana
 
794 13.5 months Stage IIIB/IV NSCLC 4 Chemotherapy
Tohoku University School of Medicine Japan 2/2006
Treatment Details: Patients: This Phase II study involved 120 patients with advanced non-small-cell lung cancer. The patients were randomly divided into two groups. Group A had 60 patients (53 men, 7 women,
 
795 13.4 months Metastatic rcc 4 Biologic therapy
Immunotherapy
M. D. Anderson Cancer Center United States 6/2006
Treatment Details: Patients: This Pilot trial involved 15 patients with metastatic renal cell carcinoma. There were 13 men and 2 women and the median age was 59. Thirteen patients had undergone prior nephrec
 
796 13.4 months Stage IIIB/IV NSCLC 4 Chemotherapy
M.D. Anderson Cancer Center United States 9/2007
Treatment Details: Patients: This phase II study involved 127 patients with locally advanced or metastatic (stage IIIB/IV) non-small-cell lung cancer. The median age was 59 years, ranging from 29 to 82. Fif
 
797 13.4 months Metastatic colorectal cancer 3 Chemotherapy
Taipei Veterans General Hospital and National Yang-Ming University China 8/2007
Treatment Details: Patients: This phase III study involved 28 patients with metastatic or recurrent colorectal cancer. The median age was 68, ranging from 33 to 82 years. Treatment: All patients were t
 
798 13.4 months GBM (supratentotial) 4 Immunotherapy
Radiation
M.D. Anderson Cancer Center United States 11/2006
Treatment Details: Patients: This phase II study involved two groups of patients with glioblastoma. The group treated with the immunotherapy (interferon beta) consisted of 55 patients who had undergone surger
 
799 13.4 months Advanced NSCLC 4 Chemotherapy
Hamamatsu University School of Medicine Japan 4/2008
Treatment Details: Patients: This phase II study involved 26 patients with advanced, untreated non-small cell lung cancer. Twenty of the patients were men and 6 patients (23%) were women. The median age was
 
800 13.4 months Metastatic colorectal cancer 5 Chemotherapy
Abramson Cancer Center United States 10/2008
Treatment Details: Patients: This phase III study involved 628 patients with metastatic colorectal cancer. They ranged in age from 25 to 88. Almost all (more than 90%) had previously been treated with surge
 
Page 80 of 187  | Previous Page  | Next Page